BCR and Friedreich ataxia: Although we cannot rule out potential effects of BCR/ABL in up-modulating the monoubiquitination of FANCD2, we propose that the most relevant effect of this oncoprotein in the FA pathway is related to the inhibited translocation of FANCD2 to the chromatin.